GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex in France
London, UK; 21 October 2013: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, “GW” or the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary…